Mediplantex National Pharmaceutical JSC (HNX:MED)

Market Cap	312.73B
Revenue (ttm)	355.39B
Net Income (ttm)	12.10B
Shares Out	12.41M
EPS (ttm)	975.46
PE Ratio	25.83
Forward PE	n/a
Dividend	900.00 (3.57%)
Ex-Dividend Date	Jul 16, 2025

Volume	100
Average Volume	24,678
Open	25,200
Previous Close	25,200
Day's Range	25,200 - 25,200
52-Week Range	22,600 - 28,600
Beta	0.14
RSI	54.84
Earnings Date	Feb 3, 2026

About HNX:MED

Mediplantex National Pharmaceutical Joint Stock Company produces and trades in pharmaceutical products in Vietnam and internationally. The company offers pharmaceutical products in various categories, including drugs from herbals; analgesics, corticosteroid, and anti-inflammatory drugs; antibiotics; cerebral circulation, heart, and lung drugs; anti-malarial, demostasis, gout, diabetes, allergies, and osteoarthritis drugs; acid amin, vitamins, and minerals; and other products. It also provides pharmaceutical chemicals and medicinal herbs; and ex...

• Industry: Pharmaceutical Preparations
• Founded: 1958
• Employees: 328
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: MED

Financial Performance

In 2024, HNX:MED's revenue was 443.14 billion, an increase of 10.03% compared to the previous year's 402.74 billion. Earnings were 15.25 billion, an increase of 29.83%.